Rapid diagnostic tests : Pros, cons and potential use in the COVID-19 management in Tunisia

Abstract

Summary :

Objectives:Diagnosis of SARS-CoV-2 infection is a major public health issue. In a context of limited diagnostic capacity with the citationsRaw technique (real-time RT-PCR), many manufacturers have developed rapid diagnostic tests (RDTs). Although very promising in theory, these tests have raised many questions. This article is a rapid review that synthesizes data regarding different types of available RDTs, their performance, their limits and their potential indications in Tunisia as proposed by a multidisciplinary group of experts.
Methods:A literature review was carried out on the websites of international organizations, governmental bodies and on INAHTA database, completed by a search of relevant scientific articles up to 1 June 2020. The synthesis of the data was submitted to a panel of experts to propose recommendations for the Tunisian context.
Results:RDTs based on the detection of antigens and antibodies have sensitivity and specificity related issues. Few validation reports are published in the scientific literature. Pending more evidence on their performance and validity, several international organizations recommend their use only for research purposes. TDRs based on antibody detection are not appropriate for the early diagnosis of COVID-19. However, validated and specific tests could provide complementary diagnostic information to citationsRaw tests.
Conclusion:Pending further evidence, the panel recommends the use of RDTs mainly for research purposes at the community level.